The Coalition on Abortion/Breast Cancer vigorously applauds a decision from the U.S. Court of Appeals for the District of Columbia Circuit in a lawsuit filed by two business owners who have religious objections to being forced by ObamaCare to provide employees with insurance coverage for abortion-inducing drugs, contraceptive steroids and sterilizations. In the case, Francis Gilardi, et al. vs. U.S. Health and Human Services, et al., the court agreed to enjoin (stop) the government’s mandate as to the Gilardi’s. 
Karen Malec, president of the Coalition on Abortion/Breast Cancer, said, “We’re encouraged the court cited the amicus brief  filed by Bioethics Defense Fund on behalf of our organization, the Polycarp Research Institute and the Breast Cancer Prevention Institute. As stated in the decision:
Equally unconvincing is the government’s assertion that the mandate averts ‘negative health consequences for both the woman and the developing fetus.’ From the outset, we note the science is debatable and may actually undermine the government’s cause. For the potential mother, as one amicus notes, the World Health Organization classifies certain oral contraceptives as carcinogens, marked by an increased risk for breast, cervical, and liver cancers. Br. of the Breast Cancer Prevention Institute, at 8-9.